Surveillance for low-grade dysplastic Barrett's oesophagus: one size fits all?

作者: Giovanni Zaninotto , Cathy Bennett

DOI: 10.1007/S00268-014-2661-5

关键词:

摘要: This paper reviews the role of low-grade dys- plasia (LGD) as a marker progression in Barrett's oesophagus (BO). Albeit with its limits due to difficulty diagnosis and low agreement among pathologists, LGD remains most relevant single prognostic factor progression, and, when is confirmed by two or three chances high- grade dysplasia invasive adenocarcinoma are high 40 %. On other hand, BO patients who remain free at several follow-up examinations seem have very likelihood progression. The should be sur- veillance programs tailored depending on presence persistent absence LGD. Ablative therapy also considered for cases where persists series follow-ups.

参考文章(52)
Sunil A Sonwalkar, Olorunda Rotimi, Nigel Scott, Eldo Verghese, Mike Dixon, Anthony TRA Axon, Simon M Everett, None, A study of indefinite for dysplasia in Barrett's oesophagus: reproducibility of diagnosis, clinical outcomes and predicting progression with AMACR (α-methylacyl-CoA-racemase) Histopathology. ,vol. 56, pp. 900- 907 ,(2010) , 10.1111/J.1365-2559.2010.03571.X
Sarah Thomson, Thomas Foubister, Elias Mossialos, World Health Organization, None, Financing health care in the European Union: challenges and policy responses Financing health care in the European Union: challenges and policy responses.. ,(2009)
Cathy Bennett, Susi Green, John DeCaestecker, Max Almond, Hugh Barr, Pradeep Bhandari, Krish Ragunath, Rajvinder Singh, Janusz Jankowski, Surgery versus radical endotherapies for early cancer and high‐grade dysplasia in Barrett's oesophagus Cochrane Database of Systematic Reviews. ,vol. 5, ,(2012) , 10.1002/14651858.CD007334.PUB4
John Y Nasr, Robert E Schoen, Prevalence of adenocarcinoma at esophagectomy for Barrett’s esophagus with high grade dysplasia Journal of gastrointestinal oncology. ,vol. 2, pp. 34- 38 ,(2011) , 10.3978/J.ISSN.2078-6891.2010.027
I.E. Gillespie, British Society of Gastroenterology Gastroenterology. ,vol. 46, pp. 235- 239 ,(1964) , 10.1016/S0016-5085(64)80069-X
Gregory Y. Lauwers, Frank V. Meriano, Juan Lechago, John C. McKechnie, Jim Schwartz, Mamoun Younes, Ray Verm, Karen Woods, Craig Johnson, Carl Schmulen, Alberto Oswaldo Barroso, Margaret Bridges, Atilla Ertan, Gulchin Ergun, The significance of "indefinite for dysplasia" grading in Barrett metaplasia Archives of Pathology & Laboratory Medicine. ,vol. 135, pp. 430- 432 ,(2011) , 10.1043/2010-0097-OA.1
Mauro Rossi, Marco Barreca, Nicola de Bortoli, Cristina Renzi, Stefano Santi, Alessandro Gennai, Massimo Bellini, Francesco Costa, Massimo Conio, Santino Marchi, Efficacy of Nissen Fundoplication Versus Medical Therapy in the Regression of Low-Grade Dysplasia in Patients With Barrett Esophagus: A Prospective Study Annals of Surgery. ,vol. 243, pp. 58- 63 ,(2006) , 10.1097/01.SLA.0000194085.56699.DB
S Y Iftikhar, P D James, R J Steele, J D Hardcastle, M Atkinson, Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma. Gut. ,vol. 33, pp. 1155- 1158 ,(1992) , 10.1136/GUT.33.9.1155
David M. Aldulaimi, Mark Cox, Chuka U. Nwokolo, Duncan E. Loft, Barrett's surveillance is worthwhile and detects curable cancers. A prospective cohort study addressing cancer incidence, treatment outcome and survival. European Journal of Gastroenterology & Hepatology. ,vol. 17, pp. 943- 950 ,(2005) , 10.1097/00042737-200509000-00010